Data from the Israeli Minister of Health in July suggested that the effectiveness of the Pfizer vaccine in preventing infection and symptomatic illness had dropped from 90 percent to only 39 percent and 41 percent, respectively. However, the levels of protection against severe illness (88 percent) and hospitalization (91.4 percent) remained high.